logo

Aethlon Medical Inc (AEMD)



Trade AEMD now with
  Date
  Headline
11/3/2020 8:06:09 AM Aethlon Names Charles Fisher CEO, Effective As Of October 30
6/18/2020 9:22:05 AM Aethlon Reports FDA Approval Of IDE Supplement For COVID-19 Patients; Stock Surges In Pre-market Trade
3/24/2020 8:59:00 AM Aethlon Reports Issuance Of European Patent For The Hemopurifier In Cancer
1/17/2020 8:51:13 AM Aethlon Medical Announces $3.77 Mln Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12/13/2019 7:05:29 AM Aethlon Medical Reports Pricing Of $5 Mln Public Offering
10/7/2019 8:33:22 AM Aethlon Medical Announces FDA Approval Of IDE For Oncology Indications
10/3/2019 8:33:55 AM Aethlon Medical Says Nasdaq Grants Aethlon Medical Extension Of Time To Regain Compliance With Continued Listing
7/1/2019 8:54:48 AM Aethlon Medical, SeaStar Medical Announce Cross-licensing Agreement
3/7/2019 8:49:38 AM Aethlon Medical Names Lisa Boswell As Director, Quality Systems And Regulatory Affairs
12/13/2018 8:30:24 AM Aethlon Medical Appoints Timothy Rodell As Interim CEO
11/27/2018 7:22:52 AM Aethlon Medical's Cancer Therapy Receives Breakthrough Device Designation From FDA
7/23/2018 8:16:15 AM Aethlon Medical Reports Issuance Of Hemopurifier Patent To Treat Life-Threatening Viruses